Insider Trading activities at Ligand Pharmaceuticals Inc (LGND)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ligand Pharmaceuticals Inc (LGND) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ligand Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 886163.

Total stock buying since 2014: $3,768,647.
Total stock sales since 2014: $189,043,873.
Total stock option exercises since 2014: $26,702,538.


 1   2 
16 insiders reported insider trading activities at Ligand Pharmaceuticals Inc (LGND):
Insider trading activities of Korenberg Matthew E
Insider trading activities of Espinoza Octavio
Insider trading activities of Gray Nancy Ryan
Insider trading activities of Higgins John L
Insider trading activities of Herman Melanie J
Insider trading activities of Lamattina John L
Insider trading activities of Knott David M
Insider trading activities of Sabba Stephen L
Insider trading activities of Desilva Nishan M
Insider trading activities of Davis Todd C
Insider trading activities of Patel Sunil
Insider trading activities of Foehr Matthew W
Insider trading activities of Aryeh Jason
Insider trading activities of Reardon Andrew
Insider trading activities of Kozarich John W
Insider trading activities of Berkman Charles S

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Ligand Pharmaceuticals Inc (LGND).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 11,010 $1,154,044 3,868 $472,656 4,812 $251,666
2024 2,500 $243,480 104,189 $9,921,891 65,287 $3,457,964
2023 4,000 $237,528 17,560 $1,350,441 12,816 $120,598
2022 2,500 $206,910 26,696 $1,978,161 38,000 $558,760
2021 0 $0 254,898 $45,649,827 334,153 $8,039,802
2020 1,000 $82,520 32,899 $3,633,177 113,842 $1,818,675
2019 17,802 $1,831,729 6,591 $668,694 61,800 $1,133,382
2018 0 $0 325,024 $69,648,591 186,997 $5,068,445
2017 0 $0 192,032 $23,226,551 81,858 $1,253,468
2016 0 $0 102,337 $11,422,797 46,921 $1,190,727
2015 0 $0 231,566 $21,071,087 160,254 $3,809,051
2014 275 $12,436 0 $0 0 $0

Table 2. Monthly summary of insider trading at Ligand Pharmaceuticals Inc (LGND).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-09 0 $0 467 $76,008 0 $0
2025-08 0 $0 467 $61,586 0 $0
2025-07 0 $0 934 $116,750 0 $0
2025-06 0 $0 1,000 $114,312 0 $0
2025-05 11,010 $1,154,044 1,000 $104,000 0 $0
2025-04 0 $0 0 $0 2,406 $125,833
2025-01 0 $0 0 $0 2,406 $125,833
2024-11 0 $0 2,406 $297,501 2,406 $125,833
2024-09 0 $0 19,322 $1,974,241 18,240 $958,506
2024-08 2,500 $243,480 38,603 $3,942,613 2,253 $126,318
2024-05 0 $0 41,825 $3,554,503 16,917 $941,904
2024-04 0 $0 0 $0 5,299 $239,672
2024-03 0 $0 1,893 $140,649 18,908 $993,490
2024-02 0 $0 140 $12,384 1,264 $72,241
2023-09 4,000 $237,528 0 $0 0 $0
2023-05 0 $0 17,260 $1,329,464 12,816 $120,598
2023-03 0 $0 300 $20,977 0 $0
2022-12 0 $0 10,000 $618,660 20,000 $255,600
2022-11 0 $0 11,696 $911,451 10,000 $127,800
2022-09 0 $0 5,000 $448,050 0 $0
2022-05 2,500 $206,910 0 $0 8,000 $175,360
2021-11 0 $0 18,995 $3,083,336 17,023 $901,466
2021-08 0 $0 8,840 $969,509 9,982 $537,580
2021-05 0 $0 0 $0 4,835 $48,930

Table 3. Detailed insider trading at Ligand Pharmaceuticals Inc (LGND)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-09-02 Kozarich John W (Director) Sale 467 162.76 76,008
2025-08-01 Kozarich John W (Director) Sale 467 131.88 61,586
2025-07-10 Kozarich John W (Director) Sale 934 125.00 116,750
2025-06-23 Reardon Andrew (CLO & Secretary) Sale 500 114.08 57,042
2025-06-10 Reardon Andrew (CLO & Secretary) Sale 500 114.54 57,270
2025-05-15 Reardon Andrew (CLO & Secretary) Sale 1,000 104.00 104,000
2025-05-09 Espinoza Octavio (Chief Financial Officer) Buy 1,500 104.14 156,217
2025-05-09 Davis Todd C (Chief Executive Officer) Buy 9,510 104.92 997,827
2025-04-01 Sabba Stephen L Option Ex 2,406 52.30 125,833
2025-01-17 Kozarich John W (Director) Option Ex 2,406 52.30 125,833
2024-11-27 Lamattina John L (Director) Sale 2,406 123.65 297,501
2024-11-27 Lamattina John L (Director) Option Ex 2,406 52.30 125,833
2024-09-23 Reardon Andrew (CLO & Secretary) Sale 2,000 99.60 199,202
2024-09-23 Reardon Andrew (CLO & Secretary) Option Ex 2,000 52.27 104,540
2024-09-23 Korenberg Matthew E (President & COO) Sale 9,772 101.24 989,287
2024-09-23 Korenberg Matthew E (President & COO) Option Ex 9,772 51.41 502,427
2024-09-20 Espinoza Octavio (Chief Financial Officer) Sale 1,275 103.93 132,512
2024-09-20 Korenberg Matthew E (President & COO) Sale 6,275 104.10 653,240
2024-09-20 Korenberg Matthew E (President & COO) Option Ex 4,982 49.99 249,050
2024-09-17 Espinoza Octavio (Chief Financial Officer) Option Ex 1,486 68.97 102,489
2024-08-28 Reardon Andrew (CLO & Secretary) Sale 1,500 106.39 159,591
2024-08-28 Reardon Andrew (CLO & Secretary) Option Ex 1,500 52.27 78,405
2024-08-28 Espinoza Octavio (Chief Financial Officer) Option Ex 753 63.63 47,913
2024-08-26 Korenberg Matthew E (President & COO) Sale 11,389 105.67 1,203,464
2024-08-23 Korenberg Matthew E (President & COO) Sale 6,312 104.61 660,317
2024-08-22 Korenberg Matthew E (President & COO) Sale 1,157 105.54 122,109
2024-08-09 Korenberg Matthew E (President & COO) Sale 18,245 98.50 1,797,132
2024-08-08 Davis Todd C (Chief Executive Officer) Buy 2,500 97.39 243,480
2024-05-17 Espinoza Octavio (Chief Financial Officer) Sale 5,156 86.66 446,803
2024-05-17 Espinoza Octavio (Chief Financial Officer) Option Ex 6,917 60.60 419,204
2024-05-16 Espinoza Octavio (Chief Financial Officer) Sale 2,264 86.00 194,710
2024-05-15 Espinoza Octavio (Chief Financial Officer) Sale 5,873 86.01 505,148
2024-05-14 Korenberg Matthew E (President & Chief Operating) Sale 14,158 85.38 1,208,852
2024-05-13 Korenberg Matthew E (President & Chief Operating) Sale 3,440 84.54 290,827
2024-05-09 Reardon Andrew (Chief Legal Officer &) Sale 10,000 83.05 830,450
2024-05-09 Reardon Andrew (Chief Legal Officer &) Option Ex 10,000 52.27 522,700
2024-05-09 Gray Nancy Ryan (Director) Sale 934 83.20 77,713
2024-04-30 Aryeh Jason (Director) Option Ex 2,406 52.30 125,833
2024-04-24 Kozarich John W (Director) Option Ex 2,893 39.35 113,839
2024-03-25 Davis Todd C (Chief Executive Officer) Option Ex 16,015 62.03 993,490
2024-03-05 Sabba Stephen L Sale 1,893 74.30 140,649
2024-03-05 Sabba Stephen L Option Ex 2,893 .00 0
2024-02-28 Espinoza Octavio (Chief Financial Officer) Sale 140 88.46 12,384
2024-02-28 Espinoza Octavio (Chief Financial Officer) Option Ex 1,264 57.15 72,241
2023-09-22 Davis Todd C (CHIEF EXECUTIVE OFFICER) Buy 4,000 59.38 237,528
2023-05-16 Kozarich John W (Director) Sale 4,444 77.20 343,081
2023-05-10 Sabba Stephen L Sale 6,408 77.13 494,223
2023-05-10 Sabba Stephen L Option Ex 6,408 .00 0
2023-05-08 Kozarich John W (Director) Sale 6,408 76.80 492,160
2023-05-08 Kozarich John W (Director) Option Ex 6,408 18.82 120,598
2023-03-24 Reardon Andrew (See Remarks) Sale 300 69.92 20,977
2022-12-16 Higgins John L (Director) Sale 10,000 61.87 618,660
2022-12-12 Higgins John L (Director) Option Ex 20,000 12.78 255,600
2022-11-18 Higgins John L (Chief Executive Officer) Option Ex 10,000 12.78 127,800
2022-11-17 Higgins John L (Chief Executive Officer) Sale 10,000 78.32 783,169
2022-11-09 Espinoza Octavio (Chief Financial Officer) Sale 1,696 75.64 128,282
2022-09-16 Higgins John L (Chief Executive Officer) Sale 3,000 89.35 268,050
2022-09-15 Higgins John L (Chief Executive Officer) Sale 2,000 90.00 180,000
2022-05-13 Foehr Matthew W (President and COO) Buy 2,500 82.76 206,910
2022-05-09 Higgins John L (Chief Executive Officer) Option Ex 8,000 21.92 175,360
2021-11-16 Lamattina John L (Director) Sale 4,835 161.86 782,578
2021-11-16 Lamattina John L (Director) Option Ex 4,835 32.30 156,170
2021-11-12 Higgins John L (Chief Executive Officer) Sale 3,000 160.50 481,500
2021-11-11 Foehr Matthew W (President and COO) Sale 11,160 163.02 1,819,258
2021-11-11 Foehr Matthew W (President and COO) Option Ex 12,188 61.15 745,296
2021-08-04 Foehr Matthew W (President and COO) Sale 8,840 109.67 969,509
2021-08-04 Foehr Matthew W (President and COO) Option Ex 9,982 53.85 537,580
2021-05-11 Kozarich John W (Director) Option Ex 4,835 10.12 48,930
2021-02-22 Kozarich John W (Director) Option Ex 2,500 10.12 25,299
2021-02-11 Davis Todd C (Director) Option Ex 2,474 195.91 484,681
2021-02-10 Davis Todd C (Director) Sale 5,083 213.14 1,083,410
2021-02-09 Sabba Stephen L Sale 14,670 208.28 3,055,394
2021-02-09 Sabba Stephen L Option Ex 14,670 11.32 166,137
2021-02-05 Higgins John L (Chief Executive Officer) Sale 54,666 203.40 11,119,228
2021-02-05 Higgins John L (Chief Executive Officer) Option Ex 114,666 12.26 1,405,805
2021-02-04 Berkman Charles S (SVP, Gen. Counsel & Secretary) Sale 18,097 178.50 3,230,368
2021-02-04 Foehr Matthew W (President and COO) Sale 44,547 176.86 7,878,582
2021-02-04 Foehr Matthew W (President and COO) Option Ex 45,547 48.17 2,193,998
2021-01-27 Davis Todd C (Director) Option Ex 2,456 113.50 278,756
2021-01-27 Higgins John L (Chief Executive Officer) Sale 40,000 182.00 7,280,000
2021-01-27 Higgins John L (Chief Executive Officer) Option Ex 70,000 18.20 1,273,650
2021-01-25 Higgins John L (Chief Executive Officer) Sale 50,000 159.00 7,950,000
2021-01-25 Higgins John L (Chief Executive Officer) Option Ex 50,000 14.47 723,500
2020-12-08 Higgins John L (Chief Executive Officer) Option Ex 14,657 10.05 147,302
2020-11-09 Higgins John L (Chief Executive Officer) Option Ex 20,000 10.05 201,000
2020-11-02 Patel Sunil (Director) Buy 1,000 82.52 82,520
2020-08-24 Foehr Matthew W (President and COO) Sale 78 110.89 8,649
2020-08-24 Foehr Matthew W (President and COO) Option Ex 78 21.92 1,709
2020-08-21 Foehr Matthew W (President and COO) Sale 7,225 112.88 815,543
2020-08-21 Foehr Matthew W (President and COO) Option Ex 8,015 44.45 356,226
2020-07-07 Higgins John L (Chief Executive Officer) Option Ex 4,315 72.16 311,357
2020-06-04 Berkman Charles S (SVP, Gen. Counsel & Secretary) Sale 11,146 118.59 1,321,770
2020-03-13 Foehr Matthew W (President and COO) Option Ex 2,000 21.92 43,840
2020-02-27 Foehr Matthew W (President and COO) Sale 7,225 110.00 794,750
2020-02-27 Foehr Matthew W (President and COO) Option Ex 8,931 18.20 162,499
2020-02-14 Foehr Matthew W (President and COO) Sale 7,225 95.84 692,465
2020-02-14 Foehr Matthew W (President and COO) Option Ex 7,225 14.47 104,545
2020-02-13 Foehr Matthew W (President and COO) Option Ex 496 21.92 10,872
2020-02-13 Higgins John L (Chief Executive Officer) Option Ex 48,125 9.96 479,325
2019-11-12 Foehr Matthew W (President and COO) Option Ex 1,001 21.92 21,941
2019-09-05 Foehr Matthew W (President and COO) Option Ex 1,005 21.92 22,029
2019-09-03 Korenberg Matthew E (EVP,Finance & Strategy and CFO) Buy 500 86.18 43,091
2019-09-03 Aryeh Jason (Director) Buy 750 87.01 65,257
2019-08-12 Foehr Matthew W (President and COO) Option Ex 1,163 21.92 25,492
2019-08-05 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 1,093 71.03 77,630
2019-08-05 Aryeh Jason (Director) Buy 746 90.01 67,145
2019-08-02 Patel Sunil (Director) Buy 1,000 95.98 95,980
2019-08-02 Davis Todd C (Director) Buy 1,000 93.59 93,594
2019-08-01 Lamattina John L (Director) Option Ex 2,500 32.30 80,750
2019-07-31 Sabba Stephen L (Director) Sale 4,091 94.45 386,394
2019-07-31 Aryeh Jason (Director) Buy 754 93.00 70,121
2019-07-31 Higgins John L (Chief Executive Officer) Buy 1,850 95.45 176,582
2019-07-30 Aryeh Jason (Director) Buy 3,000 100.22 300,663
2019-07-29 Aryeh Jason (Director) Buy 250 106.01 26,502
2019-06-11 Aryeh Jason (Director) Buy 250 107.01 26,752
2019-06-11 Foehr Matthew W (President and COO) Option Ex 1,004 21.92 22,007
2019-05-31 Aryeh Jason (Director) Buy 500 108.51 54,255
2019-05-31 Higgins John L (Chief Executive Officer) Buy 1,000 108.20 108,202
2019-05-30 Aryeh Jason (Director) Buy 250 110.01 27,502
2019-05-29 Aryeh Jason (Director) Buy 250 111.01 27,752
2019-05-20 Aryeh Jason (Director) Buy 250 112.01 28,002
2019-05-14 Aryeh Jason (Director) Buy 250 112.51 28,127
2019-05-14 Kozarich John W (Director) Sale 2,500 112.92 282,300
2019-05-14 Kozarich John W (Director) Option Ex 2,500 17.88 44,700
2019-05-14 Higgins John L (Chief Executive Officer) Buy 2,500 113.50 283,750
2019-03-14 Foehr Matthew W (President and COO) Option Ex 14,894 9.97 148,493
2019-03-13 Aryeh Jason (Director) Buy 202 112.51 22,727
2019-03-13 Higgins John L (Chief Executive Officer) Buy 2,500 114.29 285,725
2019-01-10 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 2,850 50.87 144,970
2019-01-10 Higgins John L (Chief Executive Officer) Option Ex 33,790 16.14 545,370
2018-12-17 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 3,400 21.92 74,528
2018-12-12 Foehr Matthew W (President and COO) Option Ex 7,999 9.97 79,750
2018-10-24 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 3,900 18.20 70,960
2018-10-12 Davis Todd C (Director) Option Ex 5,083 104.53 531,300
2018-10-11 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 2,000 14.47 28,940
2018-10-08 Davis Todd C (Director) Sale 2,500 253.99 634,977
2018-10-01 Foehr Matthew W (President and COO) Sale 12,000 273.88 3,286,560
2018-10-01 Foehr Matthew W (President and COO) Option Ex 14,088 12.22 172,155
2018-10-01 Kozarich John W (Director) Sale 2,500 275.04 687,610
2018-09-17 Berkman Charles S (SVP, Gen. Counsel & Secretary) Sale 2,813 250.69 705,182
2018-09-17 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 2,813 100.38 282,368
2018-09-04 Sabba Stephen L (Director) Sale 5,000 255.05 1,275,250
2018-09-04 Sabba Stephen L (Director) Option Ex 5,000 13.23 66,150
2018-09-04 Berkman Charles S (SVP, Gen. Counsel & Secretary) Sale 19,417 254.99 4,951,063
2018-09-04 Berkman Charles S (SVP, Gen. Counsel & Secretary) Option Ex 19,417 59.60 1,157,214
2018-09-04 Foehr Matthew W (President and COO) Sale 12,000 255.01 3,060,084
2018-09-04 Foehr Matthew W (President and COO) Option Ex 13,044 12.22 159,397
2018-09-04 Lamattina John L (Director) Sale 3,335 254.96 850,291
2018-09-04 Lamattina John L (Director) Option Ex 3,335 12.53 41,787
2018-08-30 Higgins John L (Chief Executive Officer) Sale 3,500 258.25 903,875
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of LGND listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ligand Pharmaceuticals Inc (symbol LGND, CIK number 886163) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.